The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction.
暂无分享，去创建一个
L. Murray | D. Kerr | S. Kaye | D. Jodrell | J. Cassidy | B. Whiting | J. Morrison | A. Cook
[1] O. S. Nielsen,et al. Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. J. Cersosimo,et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Mcvie,et al. Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin. , 1984, European journal of cancer & clinical oncology.
[4] S. Peerless,et al. Natural history of intracranial aneurysms. , 1981, The New England journal of medicine.
[5] G. Wilkinson,et al. Reduction of liver blood flow and propranolol metabolism by cimetidine. , 1981, The New England journal of medicine.
[6] I. Macdonald,et al. Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. , 1980, British medical journal.
[7] N. Gerber,et al. Drug interactions with cimetidine: an update. , 1985, Pharmacology & therapeutics.
[8] J. Robert. Extraction of Anthracyclines from Biological Fluids for HPLC Evaluation , 1980 .